Evidence map›Paper›PMID 41354396›Full record

ArticleNeuroImage2025

Neurochemical changes in GABA+, Glx, and the excitatory/inhibitory ratio in the calcarine cortex with healthy aging.

Ilenia Salsano, Ryan J Glesinger, Jason A John, Grant M Garrison, Lucy K Horne, Grace C Ende, Danielle L Rice, Anna T Coutant, Kennedy A Kress, Aubrie J Petts and 2 more

Abstract read
In one paragraph

Article in NeuroImage, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ilenia SalsanoInstitute for Human Neuroscience, Boys Town National Research Hospital, Boys Town, NE, USA; Center for Pediatric Brain Health, Boys Town National Research Hospital, Boys Town, NE, USA.
Ryan J GlesingerInstitute for Human Neuroscience, Boys Town National Research Hospital, Boys Town, NE, USA; Center for Pediatric Brain Health, Boys Town National Research Hospital, Boys Town, NE, USA.
Jason A JohnInstitute for Human Neuroscience, Boys Town National Research Hospital, Boys Town, NE, USA; Center for Pediatric Brain Health, Boys Town National Research Hospital, Boys Town, NE, USA.
Grant M GarrisonInstitute for Human Neuroscience, Boys Town National Research Hospital, Boys Town, NE, USA; Center for Pediatric Brain Health, Boys Town National Research Hospital, Boys Town, NE, USA.
Lucy K HorneInstitute for Human Neuroscience, Boys Town National Research Hospital, Boys Town, NE, USA; Center for Pediatric Brain Health, Boys Town National Research Hospital, Boys Town, NE, USA.
Grace C EndeInstitute for Human Neuroscience, Boys Town National Research Hospital, Boys Town, NE, USA; Center for Pediatric Brain Health, Boys Town National Research Hospital, Boys Town, NE, USA.
Danielle L RiceInstitute for Human Neuroscience, Boys Town National Research Hospital, Boys Town, NE, USA; Center for Pediatric Brain Health, Boys Town National Research Hospital, Boys Town, NE, USA.
Anna T CoutantInstitute for Human Neuroscience, Boys Town National Research Hospital, Boys Town, NE, USA; Center for Pediatric Brain Health, Boys Town National Research Hospital, Boys Town, NE, USA.
Kennedy A KressInstitute for Human Neuroscience, Boys Town National Research Hospital, Boys Town, NE, USA; Center for Pediatric Brain Health, Boys Town National Research Hospital, Boys Town, NE, USA.
Aubrie J PettsInstitute for Human Neuroscience, Boys Town National Research Hospital, Boys Town, NE, USA; Center for Pediatric Brain Health, Boys Town National Research Hospital, Boys Town, NE, USA.
Georg OeltzschnerRussell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Tony W WilsonInstitute for Human Neuroscience, Boys Town National Research Hospital, Boys Town, NE, USA; Center for Pediatric Brain Health, Boys Town National Research Hospital, Boys Town, NE, USA; Department of Pharmacology & Neuroscience, Creighton University, Omaha, NE, USA. Electronic address: tony.wilson@boystown.org.

Funding

Stress-Induced Aberrations in the Mitochondrial Redox Environment Impact Developing Neural Circuits Supporting Cognitive ControlP20GM144641 · NIGMS · FATHER FLANAGAN'S BOYS' HOME · PI Giorgia Picci · 2022 to 2026
$15.1M
Suppression of Pathological Spontaneous Cortical Dynamics and Inflammation in NeuroHIVR01DA056223 · NIDA · FATHER FLANAGAN'S BOYS' HOME · PI Tony W. Wilson · 2022 to 2026
$3.4M
THE PROGRESSIVE ELEVATION OF SPONTANEOUS CORTICAL ACTIVITY IN HAND (PESCAH) PROJECTR01MH116782 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI WILSON, TONY W · 2018 to 2022
$3.4M
Dynamic Functional Mapping of Alzheimer's Spectrum and HIV-related Brain DysfunctionR01NS141729 · NINDS · FATHER FLANAGAN'S BOYS' HOME · PI Tony W. Wilson · 2024 to 2026
$2.4M
Next-Generation MEG Imaging for Quantifying Cortical-Subcortical Dynamics in the Context of HIV and Cannabis UseR01DA059542 · NIDA · FATHER FLANAGAN'S BOYS' HOME · PI Tony W. Wilson · 2024 to 2026
$1.9M
Coupling of Inflammasome Cascades and Aberrant Neural Oscillatory Dynamics in NeuroHIVR01DA059877 · NIDA · FATHER FLANAGAN'S BOYS' HOME · PI Tony W. Wilson · 2024 to 2026
$1.7M
Model Selection for Magnetic Resonance SpectroscopyR01EB035529 · NIBIB · JOHNS HOPKINS UNIVERSITY · PI Georg Oeltzschner · 2024 to 2026
$1.7M
Towards a comprehensive neurometabolic profile in patients with mild cognitive impairment.R00AG062230 · NIA · JOHNS HOPKINS UNIVERSITY · PI OELTZSCHNER, GEORG · 2021 to 2023
$735k
General Linear Modeling For Magnetic Resonance SpectroscopyR21EB033516 · NIBIB · JOHNS HOPKINS UNIVERSITY · PI OELTZSCHNER, GEORG · 2022 to 2024
$670k
NIA NIH HHS R00 AG062230NIBIB NIH HHS R01 EB035529NIBIB NIH HHS R21 EB033516NIDA NIH HHS R01 DA056223NIDA NIH HHS R01 DA059542NIDA NIH HHS R01 DA059877NIGMS NIH HHS P20 GM144641NIMH NIH HHS R01 MH116782NINDS NIH HHS R01 NS141729
6 · The paper itself

Abstract

Aging has been associated with widespread alterations in neural structure and function, but the underlying biochemical changes remain less understood despite recent neurophysiological work suggesting age-related alterations in the excitatory/inhibitory (E/I) balance. In the current study, we used ¹H-MRS to quantify levels of excitatory (Glx: glutamate + glutamine) and inhibitory (GABA+: GABA + macromolecules) neurotransmitters in the calcarine cortex in 187 healthy adults (19-79 years-old). These neurotransmitter estimates were used to compute the E/I ratio, and all three parameters were examined for aging effects. Given our large sample, we also conducted supplementary analyses to estimate the concentration of secondary metabolites commonly implicated in aging, including total creatine (tCr), total N-acetyl aspartate (tNAA), total choline (tCho), and myo-inositol (mI). Following best practices, metabolite concentrations were estimated relative to the unsuppressed water signal and corrected for voxel tissue composition (i.e., gray matter, white matter, CSF). Our results indicated significant age-related declines in both GABA+ and Glx, along with a reduction in the E/I ratio, suggesting diminished inhibitory and excitatory tone with advancing age. We also found a decline in tNAA and an increase in tCr with increasing age. In summary, we provide compelling evidence through one of the largest studies of its kind for age-related shifts in excitatory and inhibitory neurotransmitter levels in the visual cortex. These changes may be critical to well-known, age-related physiological changes, including reduced neural selectivity and processing efficiency. These findings provide novel evidence that neurochemical alterations may contribute to the functional declines in cortical processing seen in healthy aging.

Indexed as

Aginggamma-Aminobutyric AcidGlutamic AcidGlutamineHealthy AgingVisual CortexAdultAgedFemaleHumansMaleMiddle AgedProton Magnetic Resonance SpectroscopyYoung Adultgamma-Aminobutyric AcidGlutamic AcidGlutamineAgeCalcarine cortexGlutamateMega-pressMRSNAAtCr

Identifiers

PMID41354396
PMCPMC12757107

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.